
### [MONDO:0015905](http://purl.obolibrary.org/obo/MONDO_0015905)
**Label:** rare syndromic dyslipidemia

**Subclasses:** [MONDO:0008948](http://purl.obolibrary.org/obo/MONDO_0008948) (cerebrotendinous xanthomatosis), [MONDO:0019148](http://purl.obolibrary.org/obo/MONDO_0019148) (Wolman disease), [MONDO:0019149](http://purl.obolibrary.org/obo/MONDO_0019149) (cholesteryl ester storage disease), [MONDO:0008863](http://purl.obolibrary.org/obo/MONDO_0008863) (sitosterolemia), [MONDO:0012725](http://purl.obolibrary.org/obo/MONDO_0012725) (lipoprotein glomerulopathy), [MONDO:0010204](http://purl.obolibrary.org/obo/MONDO_0010204) (lysosomal acid lipase deficiency), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0032374](http://purl.obolibrary.org/obo/GO_0032374) (regulation of cholesterol transport), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0050750](http://purl.obolibrary.org/obo/GO_0050750) (low-density lipoprotein particle receptor binding), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0030343](http://purl.obolibrary.org/obo/GO_0030343) (vitamin D3 25-hydroxylase activity), [GO:0016298](http://purl.obolibrary.org/obo/GO_0016298) (lipase activity), [GO:0070326](http://purl.obolibrary.org/obo/GO_0070326) (very-low-density lipoprotein particle receptor binding), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0042627](http://purl.obolibrary.org/obo/GO_0042627) (chylomicron), [GO:0034380](http://purl.obolibrary.org/obo/GO_0034380) (high-density lipoprotein particle assembly), [GO:0015485](http://purl.obolibrary.org/obo/GO_0015485) (cholesterol binding), [GO:0031073](http://purl.obolibrary.org/obo/GO_0031073) (cholesterol 26-hydroxylase activity), [GO:1900221](http://purl.obolibrary.org/obo/GO_1900221) (regulation of amyloid-beta clearance), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0048771](http://purl.obolibrary.org/obo/GO_0048771) (tissue remodeling), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0031102](http://purl.obolibrary.org/obo/GO_0031102) (neuron projection regeneration), [GO:0019433](http://purl.obolibrary.org/obo/GO_0019433) (triglyceride catabolic process), [GO:0016125](http://purl.obolibrary.org/obo/GO_0016125) (sterol metabolic process), [GO:0034372](http://purl.obolibrary.org/obo/GO_0034372) (very-low-density lipoprotein particle remodeling), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0060228](http://purl.obolibrary.org/obo/GO_0060228) (phosphatidylcholine-sterol O-acyltransferase activator activity), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0042157](http://purl.obolibrary.org/obo/GO_0042157) (lipoprotein metabolic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0042632](http://purl.obolibrary.org/obo/GO_0042632) (cholesterol homeostasis), [GO:0042159](http://purl.obolibrary.org/obo/GO_0042159) (lipoprotein catabolic process), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0017127](http://purl.obolibrary.org/obo/GO_0017127) (cholesterol transporter activity), [GO:0010873](http://purl.obolibrary.org/obo/GO_0010873) (positive regulation of cholesterol esterification), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0034364](http://purl.obolibrary.org/obo/GO_0034364) (high-density lipoprotein particle), [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle), [GO:0000329](http://purl.obolibrary.org/obo/GO_0000329) (fungal-type vacuole membrane), [GO:0004771](http://purl.obolibrary.org/obo/GO_0004771) (sterol esterase activity), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0005740](http://purl.obolibrary.org/obo/GO_0005740) (mitochondrial envelope), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0033344](http://purl.obolibrary.org/obo/GO_0033344) (cholesterol efflux), [GO:0001816](http://purl.obolibrary.org/obo/GO_0001816) (cytokine production), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), [GO:0033700](http://purl.obolibrary.org/obo/GO_0033700) (phospholipid efflux), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.38%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.79%
- [GO:0034363](http://purl.obolibrary.org/obo/GO_0034363) (intermediate-density lipoprotein particle) 51.79%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 37.14%
- [GO:0034385](http://purl.obolibrary.org/obo/GO_0034385) (triglyceride-rich plasma lipoprotein particle) 37.14%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 37.14%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 37.14%


